The use of bioresorbable scaffold in clinical practice

Bernado Cortese, JIM 2017

At JIM 2017 (9-11 February, Milan, Italy), we spoke to Bernardo Cortese (Interventional Cardiology, A.O. Fatebenefratelli, Milano, Italy) about how he uses bioresorbable scaffolds in clinical practice and what he thinks of the ABSORB II three-year results.

This interview took place prior to the two-year results of ABSORB III/IV being presented at the 2017 scientific sessions of the American College of Cardiology. Read our report of that study here.

Cortese, Bernardo

Dr Bernardo Cortese is a consultant interventional cardiologist, and chief of research innovation and development at the Cardiac Department at the Clinica San Carlo, in Milan, Italy. He was one of the first experts on the use of drug eluting balloon technology, and has been primary investigator for many trials, including most recently TRANSFORM II (sirolimus-coated balloon versus everolimus eluting stent in small vessels), TRANSFORM I (sirolimus-coated balloon versus paclitaxel drug coated balloon in small vessels), and the ROCK study (optical coherence tomography guidance during left main percutaneous coronary intervention)

Add comment

Editor’s Cardiovascular Pick

    Subscribeto receive the very best in medical videos